Sustained Patient Meaningful Outcomes of Pain and Fatigue Relief and Improved Physical Functioning with Filgotinib in Rheumatoid Arthritis: A Post Hoc Analysis

被引：0
|
作者：
Alten, Rieke [1 ]
Fautrel, Bruno [2 ,3 ]
Conaghan, Philip G. [4 ,5 ]
de Vries, Dick [6 ]
Faes, Margaux [7 ]
Piovesan, Mercedes [8 ]
Van Beneden, Katrien [9 ]
Watson, Chris [10 ]
Weel-Koenders, Angelique E. A. M. [11 ,12 ]
Feist, Eugen [13 ]
de Vlam, Kurt [14 ,15 ]
机构：
[1] Univ Med Berlin, Dept Internal Med & Rheumatol, Schlosspark Klin, Berlin, Germany
[2] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMRS 1136, Paris, Ile De France, France
[3] Sorbonne Univ, Hop Pitie Salpetriere, Assistance Publ Hop Paris, Dept Rhumatol, Paris, Ile De France, France
[4] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England
[5] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, England
[6] Galapagos BV, Clin Dev, Leiden, Netherlands
[7] Galapagos NV, Biostat, Mechelen, Belgium
[8] Galapagos Biopharma Spain SLU, Med Affairs, Madrid, Spain
[9] Galapagos NV, Med Affairs, Mechelen, Belgium
[10] Galapagos Biotech Ltd, Med Affairs, Cambridge, England
[11] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands
[12] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[13] Otto von Guericke Univ, Helios Clin Vogelsang Gommern, Department Rheumatol, Gommern, Germany
[14] UZ Leuven, Dept Rheumatol, Leuven, Belgium
[15] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0518
引用
收藏
页码：1052 / 1055
页数：4
相关论文
共 50 条
  • [21] Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept
    Laure Gossec
    Souhila Ahdjoudj
    Evo Alemao
    Vibeke Strand
    Rheumatology and Therapy, 2017, 4 : 99 - 109
  • [22] Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept
    Gossec, Laure
    Ahdjoudj, Souhila
    Alemao, Evo
    Strand, Vibeke
    RHEUMATOLOGY AND THERAPY, 2017, 4 (01) : 99 - 109
  • [23] Distinct Treatment Responses in Patients with Rheumatoid Arthritis Receiving Filgotinib 200 Mg over 12 Months: A Post Hoc Analysis of FINCH 1
    Taylor, Peter C.
    Tanaka, Yoshiya
    Aiello, Emily
    Debray, Thomas P. A.
    Watson, Chris
    Harris, Kristina
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2593 - 2595
  • [24] EFFICACY OF FILGOTINIB IN RHEUMATOID ARTHRITIS BY AGE, BODY WEIGHT, BODY MASS INDEX: POST HOC SUBGROUP ANALYSIS OF TWO PHASE 3 TRIALS
    Tanaka, Yoshiya
    Curtis, Jeffrey
    Wassenberg, Siegfried
    Kiely, Patrick
    Ye, Lei
    Yin, Zhaoyu
    Downie, Bryan
    Enomoto, Hiroyuki
    Strengholt, Sander
    Akhdar, Ali
    Watson, Chris
    Atsumi, Tatsuya
    RHEUMATOLOGY, 2022, 61
  • [25] DISTINCT TREATMENT RESPONSES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING FILGOTINIB 200 MG OVER 12 MONTHS: A POST HOC ANALYSIS OF FINCH 1
    Taylor, P. C.
    Tanaka, Y.
    Aiello, E.
    Debray, T.
    Watson, C.
    Harris, K.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 720 - 721
  • [26] Post-hoc-Analysis shows Association of patient-reported Outcomes with sustained clinical Response
    不详
    VISCERAL MEDICINE, 2016, 32 (01) : 65 - 65
  • [27] CLINICAL OUTCOMES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AGED ≥65 YEARS: A POST HOC SUBGROUP ANALYSIS OF PHASE 2 AND 3 CLINICAL TRIALS AND ONGOING LONG-TERM EXTENSIONS
    Buch, Maya H.
    Combe, Bernard
    Gomez-Puerta, Jose A.
    Caporali, Roberto
    Gottenberg, Jacques-Eric
    Van Hoek, Paul
    Rajendran, Vijay
    Stiers, Pieter-Jan
    Van Beneden, Katrien
    Aletaha, Daniel
    Burmester, Gerd
    Westhovens, Rene
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2023, 62
  • [28] Filgotinib Significantly Improved Patient-reported Health-related Quality of Life for Patients with Active Rheumatoid Arthritis: A Post Hoc Analysis of SF-36 and HAQ-DI from Phase 3 Studies
    Bingham, Clifton, III
    Walker, David
    Nash, Peter
    Lee, Susan
    Ye, Lei
    Hu, Hao
    Khalid, Javaria Mona
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [29] Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis
    Roy Fleischmann
    Kyle Hayes
    Sung-Woo Ahn
    George J. Wan
    Mary P. Panaccio
    Daniel Karlsson
    Daniel E. Furst
    Rheumatology and Therapy, 2022, 9 : 435 - 446
  • [30] Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials
    Yoshiya Tanaka
    Tatsuya Atsumi
    Daniel Aletaha
    Beatrix Bartok
    Alena Pechonkina
    Ling Han
    Kahaku Emoto
    Shungo Kano
    Vijay Rajendran
    Tsutomu Takeuchi
    Rheumatology and Therapy, 2023, 10 : 161 - 185
12345